Plasma matrix metalloproteinase-9 and diabetic microalbuminuria: tip of the iceberg?
J
J
Yee
D000419:Albuminuria / Q000097:blood* / Q000209:etiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood*; D017315:Cilazapril / Q000627:therapeutic use; D017364:Collagenases / Q000097:blood*; D003928:Diabetic Nephropathies / Q000097:blood* / Q000150:complications*; D006801:Humans; D006978:Hypertension, Renovascular / Q000188:drug therapy / Q000209:etiology; D020781:Matrix Metalloproteinase 1; D020780:Matrix Metalloproteinase 9; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000097:blood
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D015415:Biomarkers; D019715:Tissue Inhibitor of Metalloproteinase-1; D017315:Cilazapril; D017364:Collagenases; D020780:Matrix Metalloproteinase 9; D020781:Matrix Metalloproteinase 1